All exposed this coming Monday





















Splitting the company comes to mind. Get rid of the under-performers which has kept the shares from appreciating.

In this instance, the sum of the parts don't equal the whole. The good sellers are having to work even harder to make up for the outliers.
 








Big moment after the market close, TODAY (10-24-11).

Hopefully, there will be discussion of a new Amgen, including the possibility of splitting off units to increase the share value. Selling units should also be considered. New broom sweeps clean.
 








Old Amgen back in 80's and 90's good. New Amgen of last 10 years terrible. If you want a really new Amgen, anything is better than the last 10 years IMO. Start with getting rid of your fearless leader Sharer, all of his cronies and all the worthless board members he has appointed. Then you are talking about a new Amgen.
 




















Judging from the many, many calls (posts) for Mr. Sharer's dismissal, fall upon a board, aka, bored, with poor eyesight and bad hearing.

It appears from yesterday's 1/4 report, it's business as usual and a questionable future as to the hopes of a significant share appreciation. You need a lot more than this to get the buying mood in gear. S N O R E i n g rhymes with B O R ing.

At least we get 2% dividends.
 








should I offload my stock?

It seems to hit a wall at $60.00 a share. The pipeline isn't encouraging and 1/4 report tells me there is a struggle within. With FDA breathing down their necks (EPO/Aranesp) as well as Medicare and Medicaid trying to get every discount cent they can wring out of the drugs, I don't see any big upward moves in the immediate future. I have been a very long term holder, so the share movement is not a daily concern.

Remember, this is just my studied opinion.

Some of the analysts think the shares are worth something in the 60s and even the 70s.
 




should I offload my stock?

Shares have gone nowhere for the last decade. The market cap has declined significantly. Institutional investors hold 80% of the stock. That's the only reason this "management" team and BOD are still intact. Most mutual funds and pensions stay away from influencing companies in their portfolios.

But these institutions do vote with their investment dollars. Once a few large holders such Vanguard pick up the smell of a dying company or if they get nervous about further DOJ actions, the quantum level sell-offs could be disastrous.
 




Shares have gone nowhere for the last decade. The market cap has declined significantly. Institutional investors hold 80% of the stock. That's the only reason this "management" team and BOD are still intact. Most mutual funds and pensions stay away from influencing companies in their portfolios.

But these institutions do vote with their investment dollars. Once a few large holders such Vanguard pick up the smell of a dying company or if they get nervous about further DOJ actions, the quantum level sell-offs could be disastrous.


Yes, that's a concern. But, the pending settlement money has already been discounted in the Earnings and, 3/4 billion has been set aside. So, the final settlement shouldn't hurt the stock price as the news is well known.
 




Yes, that's a concern. But, the pending settlement money has already been discounted in the Earnings and, 3/4 billion has been set aside. So, the final settlement shouldn't hurt the stock price as the news is well known.

There is no way to make this whopping fine look like an accomplishment. If Amgen does hold price, the $58/ share and 11.8 P/E says "get out" louder than it says "buy more". The DOJ action will certainly cause institutional investors and analysts to keep a close eye on Amgen. In this market, any uncertainty is a killer.

The $780,000,000 may or may not cover all the Fed fines and penalties. There is no telling the amount of civil suits that may arise. And I am sure Amgen has more skeletons in its closet.